A portrait of tissue phosphoprotein stability in the clinical tissue procurement process.
Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH, Pastore L, Sennesh J, Petricoin EF, Liotta LA
Purpose
Conclusion
Studies (3)
Purpose
This study investigated the stability of phosphoprotein levels after a cold ischemia time (post-excision delay at room temperature) of up to 120 min. Eleven tissue specimens from breast, colon, lung, ovary, uterus, skin were analyzed. Phosphoprotein levels were compared to controls that were processed as soon as possible; notably, although controls are termed "time zero" actual cold ischemia time was specimen-specific.
Summary of Findings
Every tissue type examined displayed robust alterations in the post-translational levels of 9 or more phosphoproteins (+/- 20% change compared to specimen-specific "time zero" controls) within the first 60 min of cold ischemia, although tissue-specific effects were observed. Phosphoproteins significantly affected by cold ischemia times of 60 min or less included those functioning in apoptosis, hypoxia, proliferation/survival, stress/inflammation, and as transcription factors. More specifically, significant fluctuations in phosphoprotein levels were observed in uterine specimens after 10 min of cold ischemia compared to case-matched controls frozen within 4 minutes of excision, and in lung specimens after 15 min of cold ischemia compared to case-matched controls frozen within 10 minutes of excision. Although time-dependent alterations in phosphoprotein levels were observed among both normal and cancerous lung tissue, the direction and magnitude of response were protein-specific and influenced by disease state.
Biospecimens
TissueBreastTissueColorectalTissueLungTissueOvaryTissueUterusTissueSkinPreservation Types
FrozenDiagnoses
NeoplasticMelanomaNeoplasticCarcinomaNeoplasticBenignNormalPlatforms
ProteinReverse phase protein microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition NeoplasticNormalBiospecimen Acquisition Biospecimen location BreastColonLungOvarySkinUterusBiospecimen Acquisition Cold ischemia time 60-120 min< 60 min> 120 min
Purpose
Summary of Findings
Biospecimens
TissueUterusPreservation Types
FrozenDiagnoses
NormalPlatforms
ProteinReverse phase protein microarrayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Cold ischemia time 120 min30 min45 min60 min90 minStorage Storage temperature 4 degrees CRoom temperature
Purpose
The purpose of this study was to determine if specimen incubation with phosphatase and kinase inhibitors (alone or in combination) could attenuate ischemia-induced effects on phosphoprotein levels. Breast and melanoma specimens in the presence or absence of inhibitors were assessed.
Summary of Findings
Representative phosphoproteins that increased progressively with ischemia duration were further elevated in breast specimens incubated with phosphatase inhibitors during cold ischemia; conversely, incubation with kinase inhibitors attenuated ischemia-induced increases in phosphoprotein levels. Examination of a larger subset of phosphoproteins in melanoma specimens buttressed findings in breast, with 85% of the phosphoproteins examined elevated above vehicle controls after incubation with phosphatase inhibitors during 30 min of ischemia, and 20% depressed after incubation with kinase inhibitors. Incubation of breast specimens with phosphatase and kinase inhibitors in combination attenuated ischemia-induced alterations in 15% of the 32 phosphoproteins analyzed, with specimens subjected to 5 or 90 minutes of cold ischemia time. Specimen incubation with phosphatase and kinase inhibitors in a methanol or ethanol based solution adequately preserved cellular morphology.
Biospecimens
TissueBreastTissueSkinPreservation Types
FrozenDiagnoses
NeoplasticMelanomaNeoplasticBenignPlatforms
ProteinReverse phase protein microarrayMorphologyH-and-E microscopyPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location BreastSkinBiospecimen Acquisition Cold ischemia time 10 min120 min30 min5 min60 min90 minBiospecimen Preservation Enzyme inhibitor Beta-glycerophosphateNoneSodium orthovanadateBiospecimen Preservation Kinase inhibitor GenisteinNoneStaurosporine